Biomolecular Life Holdings, Inc. (OTCPK: BIOM)
Health Care · Biotechnology · US
$0.45
-37.50% today · -77.5% 1Y
Biomolecular Life Holdings, Inc. (OTCPK: BIOM) operates in the Biotechnology industry within the Health Care sector. The company is valued at $477.72K and employs 1 people.
Over the last twelve months the share price has lost 77.5%, trading between 0.02 and 2.25.
Tweenvest scores Biomolecular Life Holdings, Inc. across four factors: quality 6/100. Its strongest factor is quality.
BIOM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $477.72K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 66.74
- 52-week high
- $2.25
- 52-week low
- $0.02
- Avg volume (3M)
- —
- Shares outstanding
- 1.06M
- Employees
- 1
- Next earnings
- —
About Biomolecular Life Holdings, Inc.
SB Technology Holdings Inc. does not have significant operations. Previously, the company was engaged in research and development of therapeutic and diagnostic pharmaceutical and medical products. SB Technology Holdings Inc. was incorporated in 1995 and is based in New York, New York. SB Technology Holdings Inc. operates as a subsidiary of KH Feelux Co., Ltd.
- ISIN
- US91822T2006
- Listed since
- Dec 7, 1999
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $265.85 | +0.34% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.79 | +0.10% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.89 | +0.53% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.19 | +0.03% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $842.16 | +0.97% |
| argenx SEENXTBR: ARGX | $65.85B | €875.60 | -2.93% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $143.99 | -0.74% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.